9th Annual Cell and Gene Therapy Symposium

Centre for Stem Cell Research (a unit of inStem, Bengaluru), Christian Medical College Campus, Vellore

CGTS 2017

2nd Annual Cell and Gene Therapy Symposium

7-8 September, 2017

Scientific Program

DAY-1: THURSDAY, 07TH SEPTEMBER, 2017

12:45 to 1:00pm

1:00 to 1:10PM

1:10 to 1:20PM

 

 Welcome and introductory remarks – Director / Principal, CMC, Vellore

Address by Dr. K. VijayRaghavan, Secretary, Department of Biotechnology (DBT), Govt. of India

Address by Dr. Soumya Swaminathan, Secretary, Department of Health Research (DHR), Govt. of India & Director General, Indian Council of Medical Research (ICMR)
Session-1: CELL & GENE THERAPY: BENCH TO BEDSIDE
Chair: Dr. Alok Srivastava
1:25 to 1:30PM Introduction to the session
1:30 to 2:00PM Gene modified cell therapies – Bench to bedside Dr. Trent Spencer

Emory University

School of Medicine, USA
2:00 to 2:30PM Gene therapy for hemoglobin disorders – From concept to the clinic Dr. Mark Walters

UCSF Benioff Children’s Hospital, USA
2:30 to 3:00PM Developing cell therapies in India – Establishing the regulatory path Dr. Rajiv Sarin

Cancer Genetics Unit, Tata Memorial Centre & Chairman, NAC-SCRT, India
Session-2:  CELL THERAPY
Chair: Dr. Velu Nair
3:00 to 3:05PM Introduction to the session
3:05 to 3:35PM Engineering gamma delta T cell therapy for cancer –

Standardizing production & IND enabling preclinical studies

 Dr. Trent Spencer

Emory University

School of Medicine, USA
3:35 to 4:05PM Gamma delta T cell based Cancer Immunotherapy: Basic Biology to Clinical Application Dr. Shubhada Chiplunkar

Advanced Centre for Treatment, Research and Education in Cancer, India
4:05 to 4:35PM Haplobanking in India – Preparing for universal cell therapy Dr. R. V. Shaji

Centre for Stem Cell Research, India
4:35 to 5:00PM

Tea Break
Session-3: GENE THERAPY FOR HEMOGLOBIN DISORDERS
Chair: Dr. Mammen Chandy
5:00 to 5:05PM Introduction to the session
5:05 to 5:35PM Lentiviral vector based gene therapy for beta thalassemia major and sickle cell disease Dr. Mark Walters

UCSF Benioff Children’s Hospital, USA
5:35 to 6:05PM Gene therapy of human hemoglobinopathies with AAV vectors Dr. Arun Srivastava

University of Florida

College of Medicine, USA
6:05 to 6:35PM Gene therapy for haemoglobinopathies: The French experience Dr. Elisa Magrin

Cell and Gene Therapy Lab, Necker Hospital, France
6:35 to 7:05PM Developing gene therapy for haemoglobin disorders in India Dr. Mohankumar Murugesan

Centre for Stem Cell Research, India
Key note lecture: EVOLUTION OF GENE THERAPY
Chair: Dr. Alok Srivastava
7:05 to 7:10PM Introduction
7:10 to 8:00PM AAV: From Almost A Virus to An Awesome Vector Dr. Arun Srivastava

University of Florida

College of Medicine, USA
8:00PM onwards

Dinner

 

DAY-2: FRIDAY, 08TH SEPTEMBER, 2017

Session-4: CANCER CELL AND GENE THERAPY
Chair: Dr. Rita Mulherkar
8:30 to 8:35AM Introduction to the session
8:35 to 9:05AM Combating cancer through targeted chemotherapy in combination with in vivo dendritic cell targeted genetic immunization Dr. Arabinda Chaudhuri

CSIR-Indian Institute of Chemical Technology, India
9:05 to 9:35AM Dendritic cell vaccine for cervical cancer Dr. Thangarajan Rajkumar

Adyar Cancer Institute, India
9:35 to 10:00AM

Tea Break
Session-5: NON-VIRAL GENE TRANSFER TECHNOLOGY
Chair: Dr. Rajiv Sarin
10:00 to 10:05AM Introduction to the session
10:05 to 10:35AM siRNA for therapeutic gene regulation Dr. Narendra Chirmule

Biocon Research Limited, India
10:35 to 11:05AM Glucocorticoid receptor: A potent cell & gene therapy target for cancer and cancer stem cells Dr. Rajkumar Banerjee

CSIR-Indian Institute of Chemical Technology, India
11:05 to 11:35AM Therapeutic Antisense Oligonucleotides based Exon Skipping Gene Editing Strategies in Duchenne Muscular Dystrophy Dr. Aravind Sankaramoorthy

Dystrophy Annihilation Research Trust, India
11:35 to 12:05PM Improving safety and efficacy of cationic nanocarrier enabled CRISPR/Cas9 based genome editing Dr. Srujan Kumar Marepally

Centre for Stem Cell Research, India
12:05 to 1:05PM

Lunch
Session-6: GENE EDITING TECHNOLOGY
Chair: Dr. R. V. Shaji
1:05 to 1:10PM Introduction to the session
1:10 to 1:40PM Expanding the genome editing toolbox Dr. Debojyoti Chakraborty

CSIR-Institute of Genomics and Integrative Biology, India
1:40 to 2:10PM CRISPR/Cas9 gene editing to correct the sickle mutation Dr. David Martin

Children’s Hospital Oakland Research Institute, USA
2:10 to 2:40PM Reactivation of fetal haemoglobin using targeted genome engineering approach Dr. Sivaprakash Ramalingam

CSIR-Institute of Genomics and Integrative Biology, India
2:40 to 3:10PM Genome editing for the gene therapy of Wiskott-Aldrich Syndrome Dr. Saravanabhavan Thangavel

Centre for Stem Cell Research, India
3:10 to 3:15PM

Conclusion remarks

Gallery

[soliloquy id=”312″]

Abstracts